injures the external urethral sphincter, stretches pelvic nerves and induces urine leakage, a behavioral sign of stress urinary incontinence. Electrical pudendal nerve stimulation accelerates recovery from urinary incontinence. The aim of the present study was to determine whether in conscious rats transcutaneous electrical stimulation (TES) of the DNC facilitates urinary continence recovery after VD.
INTRODUCTION AND OBJECTIVES: Vaginal distension (VD)
injures the external urethral sphincter, stretches pelvic nerves and induces urine leakage, a behavioral sign of stress urinary incontinence. Electrical pudendal nerve stimulation accelerates recovery from urinary incontinence. The aim of the present study was to determine whether in conscious rats transcutaneous electrical stimulation (TES) of the DNC facilitates urinary continence recovery after VD.
METHODS: Twenty adult nulliparous Wistar female rats (250e300 g) were anesthetized (ketamine, 60 mg/kg and xylazine, 7.5 mg/kg, ip) to undergo 4 h of VD (n¼8), sham VD (n¼5) or VD+TES (n¼7). In VD animals, a 10-F Foley balloon catheter was inserted into the vagina and filled with 4 ml of water for 4 h. In SH animals, the catheter was placed into the vagina but not inflated. In the VD+TES animals, 3 stimulations (immediately, and 2 and 5 days after VD) were applied to the clitoral sheath for one hour with a pair of electrodes (0.9 mA, 20 Hz and 0.2 ms of duration). Micturition behavior and urinary parameters were evaluated during 6 h of dark, before and at 1, 3, 6 and 8 days after VD or SH VD.
RESULTS: Before VD, rats show a stereotyped behavior of micturition. No rat leaked urine. Voiding frequency and voiding volume were, 10+0.7 voids and 0.59+0.2 ml, respectively. After VD, stereotyped voiding behavior decreased at 1 day. From 1 to 3 days post VD, 100% of VD rats, with and without TES, leakage urine during behaviors implicating stress such as standing to reach food, sneezing, scratching, or standing on their hind legs for vertical exploration. Six and 8 days after VD, the percent of animals dripping urine decreased with TES (day 6, 70%; day 8, 28%) compared to those without TES (day 6, 87%; day 8, 75%). A similar effect of TES was observed on the number of leaks per animal at day 8 (TES 6AE3 vs without TES 29AE7; p<0.001).
CONCLUSIONS: VD-induced behavioral signs of urinary incontinence decrease gradually after the first 5 days post VD and TES accelerates functional recovery of continence. Further studies are required to compare effectivity of TES vs direct electrical pudendal nerve stimulation (invasive technique) on nerve regeneration after VD. METHODS: Baseline symptom data from 424 participants (233 women; 191 men) with UCPPS (i.e., interstitial cystitis/ bladder pain syndrome or chronic prostatitis/ chronic pelvic pain syndrome) in the MAPP Research Network EP Study were analyzed. Consensus clustering was implemented to produce subgroups with maximal separation of baseline symptom profiles. A "mean consensus" score, using the empirical likelihood of pairs of patients being classified into the same cluster, was computed for each cluster. The resulting subgroups were evaluated in longitudinal models to investigate 48-week symptom improvement.
RESULTS: Subgroups resulting from 1,000 replications of consensus clustering were generated separately for each of four subdomains: 1) global sensory sensitivity, with maximal separation on "sensitivity to odors" (prevalence 2% vs. 88%); 2) bladder hypersensitivity with maximal separation on "pain increases as bladder fills" (prevalence 6% vs. 92%); 3) body map pain regions with maximal separation on "arm pain" (prevalence 4% vs 80%); 4) chronic overlapping pain conditions with maximal separation on "TMJ" (prevalence 8% vs 94%) (Figure) . The mean consensus scores ranged from 81% to 97%, suggesting that these patient subtypes are highly reproducible. Furthermore, over 48-weeks of follow-up, the subgroup with high prevalences of bladder hypersensitivity features (cluster 1) was less likely to improve (p<0.01) in urological pain severity, and the subgroup with high prevalences of COPC features (cluster 2) was less likely to improve (p<0.01) in urinary severity.
CONCLUSIONS: These results hold great promise for scaling consensus clustering methods to expanded symptom domains to produce stable clusters that shed new insights into clinically relevant patient subtypes with differential longitudinal profiles.
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